Best known as a type 2 diabetes treatment, metformin is also being investigated for its possible effects on PCOS and ageing.
Articles on metformin
Displaying all articles
New insights into the diabetes-dementia connection.
Scientists compared diet, rapamycin and metformin in search for longevity boost.
A promising collection of studies suggests taking antivirals such as Paxlovid during an infection could reduce the risk of developing long COVID.
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
A recent study found that among people who were overweight or obese, taking metformin during a COVID infection reduced the risk of developing long COVID by 40%.
We’ve discovered a new protein produced by the liver, and found it helps control blood sugar levels in mice. This could revolutionise the way we treat type 2 diabetes in the future.
Amyotrophic lateral sclerosis, Lou Gehrig’s disease, is a crippling, progressive neurodegenerative disease for which there is no cure. Now it seems that a diabetes drug may help some cases.
Sepsis can maim or kill within hours. Here’s how to identify the condition.
People with type 2 diabetes are putting their health at risk by not taking their medication because of side effects.
Losing weight is an effective treatment for type 2 diabetes, as well as a prudent preventive measure. Beliefs that it’s harder to lose weight when diabetic are unfounded.
The true promise of ageing research is that rather than tackling individual diseases one at a time, a single drug to treat ageing would treat all of the diseases that arise in old age, at once.
Metformin has been used to treat diabetes since the late 1950s. It is now on the World Health Organisation’s List of Essential Medicines needed for a basic health care system.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
Top contributors
-
Director and CEO, Burnet Institute
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
-
Professor, School of Biotechnology and Biomolecular Sciences, UNSW
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Research Associate, Nutrition, University of Glasgow
-
Chair of Human Nutrition, University of Glasgow
-
Clinical academic, University of Exeter
-
NHMRC Senior Lecturer, School of Medical Sciences, UNSW
-
Senior Research and Policy Officer, Burnet Institute
-
Professor of Genomic Epidemiology and Hon Consultant Rheumatologist, King's College London
-
Clinical Epidemiologist, Washington University in St. Louis
-
Head, Department of Physiology, The University of Melbourne
-
Senior Research Fellow, Burnet Institute
-
Director, Center for NeuroGenetics and Kitzman Family Professor of Molecular Genetics & Microbiology, University of Florida
-
NHMRC CDF Fellow, Senior Research Fellow, Head Metabolic Crosstalk Laboratory, The University of Melbourne